{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:32:28Z","timestamp":1783027948561,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sister Institution Network Fund of the University of Texas MD Anderson Cancer Center"},{"name":"Medical Scientific Research Foundation of Guangdong Province, China","award":["A2017009"],"award-info":[{"award-number":["A2017009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13000-018-0693-0","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T23:37:27Z","timestamp":1519688247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases"],"prefix":"10.1186","volume":"13","author":[{"given":"Changfei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"693_CR1","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/ijc.29924","volume":"138","author":"MS Linet","year":"2016","unstructured":"Linet MS, Brown LM, Mbulaiteye SM, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer. 2016;138:1862\u201374.","journal-title":"Int J Cancer"},{"key":"693_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"QP Yang","year":"2011","unstructured":"Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011;6:77.","journal-title":"Diagn Pathol"},{"key":"693_CR3","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","volume":"117","author":"SM Castellino","year":"2011","unstructured":"Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the childhood cancer survivor study. Blood. 2011;117:1806\u201316.","journal-title":"Blood"},{"key":"693_CR4","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","volume":"112","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Harris NL, Stein H, et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112:4384\u201399.","journal-title":"Blood"},{"key":"693_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/mco.2014.425","volume":"3","author":"LM Sherief","year":"2015","unstructured":"Sherief LM, Elsafy UR, Abdelkhalek ER, et al. Disease patterns of pediatric non-Hodgkin lymphoma: a study from a developing area in Egypt. Mol Clin Oncol. 2015;3:139\u201344.","journal-title":"Mol Clin Oncol"},{"key":"693_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pcl.2014.09.010","volume":"62","author":"CE Allen","year":"2015","unstructured":"Allen CE, Kelly KM, Bollard CM. Pediatric lymphomas and Histiocytic disorders of childhood. Pediatr Clin N Am. 2015;62:139\u201365.","journal-title":"Pediatr Clin N Am"},{"key":"693_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","volume":"2016","author":"JT Sandlund","year":"2016","unstructured":"Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.Hematology am soc Hematol Educ program. Hematology Am Soc Hematol Educ Program. 2016;2016:589\u201397.","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"693_CR8","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","volume":"117","author":"SD Dojcinov","year":"2011","unstructured":"Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726\u201335.","journal-title":"Blood"},{"key":"693_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2015-06-648097","volume":"126","author":"J Said","year":"2015","unstructured":"Said J. The expanding spectrum of EBV+ lymphomas. Blood. 2015;126:827\u20138.","journal-title":"Blood"},{"key":"693_CR10","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"693_CR11","volume-title":"WHO classification of Tumours of Haematopoietic and lymphoid tissues (IARC WHO classification of Tumours) revised 4th edition","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and lymphoid tissues (IARC WHO classification of Tumours) revised 4th edition. Lyon: IARC Press; 2017."},{"key":"693_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44:1321\u20135.","journal-title":"Nat Genet"},{"key":"693_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789\u2013802.","journal-title":"Nat Rev Cancer"},{"key":"693_CR14","doi-asserted-by":"publisher","first-page":"80073","DOI":"10.18632\/oncotarget.20684","volume":"8","author":"C Bigenwald","year":"2017","unstructured":"Bigenwald C, Galimard J-E, Quero L, et al. Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients. Oncotarget. 2017;8:80073\u201382.","journal-title":"Oncotarget"},{"key":"693_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.humpath.2013.09.015","volume":"45","author":"MR Ambrosio","year":"2014","unstructured":"Ambrosio MR, Rocca BJ, Barone A, et al. Primary anorectal Hodgkin lymphoma: report of a case and review of the literature. Hum Pathol. 2014;45:648\u201352.","journal-title":"Hum Pathol"},{"key":"693_CR16","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","volume":"33","author":"V Minard Colin","year":"2015","unstructured":"Minard Colin V, Brugi\u00e8res L, Reiter A, et al. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33:2963\u201374.","journal-title":"J Clin Oncol"},{"key":"693_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2141.2011.09024.x","volume":"156","author":"RR Miles","year":"2012","unstructured":"Miles RR, Arnold S, Cairo MS. Risk factors and treatment of childhood and adolescent Burkitt lymphoma\/leukaemia. Br J Haematol. 2012;156:730\u201343.","journal-title":"Br J Haematol"},{"key":"693_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5045\/br.2014.49.4.246","volume":"49","author":"JY Han","year":"2014","unstructured":"Han JY, Suh JK, Lee SW, et al. Clinical characteristics and treatment outcomes of children with anaplastic large cell lymphoma: a single center experience. Blood Res. 2014;49:246\u201352.","journal-title":"Blood Res"},{"key":"693_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","volume":"50","author":"Anonymous","year":"2000","unstructured":"Anonymous. The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma study Group of Japanese Pathologists. Pathol Int. 2000;50:696\u2013702.","journal-title":"Pathol Int"},{"key":"693_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.14044","volume":"173","author":"V Pillai","year":"2016","unstructured":"Pillai V, Tallarico M, Bishop MR, et al. Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents. Br J Haematol. 2016;173:573\u201381.","journal-title":"Br J Haematol"},{"issue":"18","key":"693_CR21","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","volume":"122","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122(18):3101\u201310.","journal-title":"Blood"},{"key":"693_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.seminhematol.2015.01.009","volume":"52","author":"K Karube","year":"2015","unstructured":"Karube K, Campo E. MYC alterations in diffuse large B-cell lymphomas. Semin Hematol. 2015;52:97\u2013106.","journal-title":"Semin Hematol"},{"key":"693_CR23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2014.1.90","volume":"2014","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH. Diagnosis of \u2018double hit\u2019 diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology Am Soc Hematol Educ Program. 2014;2014:90\u20139.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"693_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3324\/haematol.2010.030809","volume":"96","author":"I Oschlies","year":"2011","unstructured":"Oschlies I, Burkhardt B, Salaverria I, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica. 2011;96:262\u20138.","journal-title":"Haematologica"},{"key":"693_CR25","unstructured":"Armstrong AA, Alexander FE, Paes RP, etal. Association of Epstein-Barr Virus with pediatric hodgkin' disease. AM J Pathol. 1993;142(6):1683\u20138."},{"key":"693_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","volume":"45","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kim Y, Choi JW, et al. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin'slymphoma: a meta-analysis. Arch Med Res. 2014;45:417\u201331.","journal-title":"Arch Med Res"},{"key":"693_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","volume":"38","author":"AR Huppmann","year":"2014","unstructured":"Huppmann AR, Nicolae A, Slack GW, et al. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol. 2014;38:316\u201324.","journal-title":"Am J Surg Pathol"},{"key":"693_CR28","doi-asserted-by":"publisher","unstructured":"Zaheen A, Delabie J, Vajpeyi R, et al. The first report of a previously undescribed EBV-negative NK-cell lymphoma of the GI tract presenting as chronic diarrhoea with eosinophilia. BMJ Case Rep. 2015;2015 \n                    https:\/\/doi.org\/10.1136\/bcr-2015-212103\n                    \n                  .","DOI":"10.1136\/bcr-2015-212103"},{"key":"693_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO;2-0","volume":"73","author":"AK Chiang","year":"1997","unstructured":"Chiang AK, Chan AC, Srivastava G, et al. Nasal T\/natural killer (NK) -cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer. 1997;73:332\u20138.","journal-title":"Int J Cancer"},{"key":"693_CR30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S1470-2045(16)30148-6","volume":"17","author":"Z Li","year":"2016","unstructured":"Li Z, Xia Y, Feng LN, et al. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol. 2016;17:1240\u20137.","journal-title":"Lancet Oncol"},{"key":"693_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)64697-4","volume":"156","author":"RF Ambinder","year":"2000","unstructured":"Ambinder RF. Gammaherpesviruses and \u201chit-and-run\u201dOncogenesis. Am J Pathol. 2000;156:1\u20133.","journal-title":"Am J Pathol"},{"key":"693_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmicb.2017.00229","volume":"8","author":"L Mundo","year":"2017","unstructured":"Mundo L, Ambrosio MR, Picciolini M, et al. Unveiling another missing piece in EBV-driven Lymphomagenesis: EBV-encoded MicroRNAs expression in EBER-negative Burkitt lymphoma cases. Front Microbiol. 2017;8:229.","journal-title":"Front Microbiol"},{"key":"693_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/his.12997","volume":"69","author":"MR Ambrosio","year":"2016","unstructured":"Ambrosio MR, Lo Bello G, Amato T, et al. The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre? Histopathology. 2016;69:885\u20136.","journal-title":"Histopathology"},{"issue":"10","key":"693_CR34","doi-asserted-by":"publisher","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L, et al. Distinct viral and mutational Spectrum of endemic Burkitt lymphoma. PLoS Pathog. 2015;11(10):e1005158.","journal-title":"PLoS Pathog"},{"key":"693_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/ajcp\/aqv011","volume":"145","author":"T Amato","year":"2016","unstructured":"Amato T, Abate F, Piccaluga P, et al. Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic Burkitt lymphoma suggests antigen drive activation of BCR as opposed to sporadic Burkitt lymphoma. Am J Clin Pathol. 2016;145:116\u201327.","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"693_CR36","first-page":"609","volume":"33","author":"M Rowe","year":"2014","unstructured":"Rowe M, Fitzsimmons L, Bell AI. Epstein-Barr virus and Burkitt lymphoma. Chin J Cancer. 2014;33(12):609\u201319.","journal-title":"Chin J Cancer"},{"key":"693_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","volume":"156","author":"I Magrath","year":"2012","unstructured":"Magrath I. Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol. 2012;156:744\u201356.","journal-title":"Br J Haematol"},{"key":"693_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae A, Pittaluga S, Abdullah S, et al. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood. 2015;126:863\u201372.","journal-title":"Blood"},{"key":"693_CR39","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/ijc.28942","volume":"135","author":"M Cohen","year":"2014","unstructured":"Cohen M, Narbaitz M, Metrebian F, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients. Int J Cancer. 2014;135:2816\u201324.","journal-title":"Int J Cancer"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0693-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T12:18:38Z","timestamp":1551269918000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-018-0693-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1186\/s13000-018-0693-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was ethically approved by Sun Yat-sen University Cancer Center IRB (Approval No: YB2017-030), and has been granted exemption from requiring informed consent to participate from participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}